NLA Resources
Knowledge Center
Membership Resources
Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.
After making your filter selections, please scroll down to see results.
S7E2: Addressing Obesity and Weight Loss Challenges: Implications for Cardiometabolic Health
In this episode of Lipid Insights, host Dr. Peter H. Jones is joined by renowned experts Robert H. Eckel, MD, FNLA and Samuel M. Kim,…
Practical Pearls – Promoting Lp(a) Awareness and Testing for Risk…
Update on Familial Hypercholesterolemia: An Expert Clinical Consensus from the National Lipid Association
This Expert Clinical Consensus provides redefined diagnostic criteria, updated ICD-10 codes, and guidance on genetic testing and cascade screening.
S7E1: Changing the FH Playbook: Diagnosis and Treatment Updates from the NLA
Hosted by Dave Dixon, PharmD, CLS, FNLA, this episode features an in-depth discussion with three key authors of the NLA’s new statement providing updated guidance…
Dietary Patterns & Nutrition Interventions for Individuals with Dyslipidemia
The mission of the National Lipid Association (NLA) is “to enhance the science and practice of lipidology and promote optimal cardiometabolic health.” The NLA leadership…
S6E13: The Next Era of Prevention: Rethinking Cardiovascular Health from the Ground Up
Dr. Peter Jones welcomes Dr. Nihar Desai for a forward-looking discussion on the future of cardiovascular prevention. From implementation science to performance measurement, this episode…
US Food and Drug Administration Approves LIB Therapeutics’ LEROCHOL™ (lerodalcibep-liga) for Adults with Elevated LDL Cholesterol
CINCINNATI, Ohio – December 15, 2025 – LIB Therapeutics Inc. (LIB), a privately held biopharmaceutical company with a singular focus on helping high-risk patients achieve their…